| ARG1 | Arginase 1 |
| BC | breast cancer |
| CSF-1R | Colony stimulating factor receptor 1 |
| DFS | disease-free survival |
| D-THP1 | differentiated THP1 cells (macrophages) |
| ER | oestrogen receptor |
| GEM | gemcitabine |
| G-MDSCs | granulocytic myeloid-derived suppressor cells |
| HER2 | human epidermal growth factor receptor 2 |
| I.P. | intraperitoneal |
| I.V. | intravenous |
| IFNg | Interferon Gamma |
| IL4 | Interleukin 4 |
| iNOS | inducible Nitric Oxide Synthase |
| MDSC | myeloid-derived suppressor cells |
| M-MDSCs | monocytic myeloid-derived suppressor cells |
| OS | Overall Survival |
| PD-1 | programmed cell death protein 1 |
| PD-L1 | programmed death ligand 1 |
| PR | progesterone receptor |
| ROS | Reactive Oxygen Species |
| TAMs | tumour associated macrophages |
| TILs | tumour infiltrating lymphocytes |
| TME | tumour microenvironment |
| TNBC | triple negative breast cancer |
| TNFα | Tumour Necrosis Factor Alpha |
| T-regs | Regulatory T-cells |